{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:01:52Z","timestamp":1791223312605,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Claude Leon Foundation South Africa"},{"name":"National Research Foundation (NRF) South Africa"},{"name":"South African Research Chair Initiative of the Department of Science and Technology (DST)"},{"DOI":"10.13039\/501100001322","name":"Medical Research Council (MRC) South Africa","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.vaccine.2010.10.045","type":"journal-article","created":{"date-parts":[[2010,11,19]],"date-time":"2010-11-19T09:21:31Z","timestamp":1290158491000},"page":"1339-1346","source":"Crossref","is-referenced-by-count":58,"title":["Blocking IL-1\u03b1 but not IL-1\u03b2 increases susceptibility to chronic Mycobacterium tuberculosis infection in mice"],"prefix":"10.1016","volume":"29","author":[{"given":"Reto","family":"Guler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suraj P.","family":"Parihar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunther","family":"Spohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Brombacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin F.","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4\u20135","key":"10.1016\/j.vaccine.2010.10.045_bib0005","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1359-6101(02)00020-5","article-title":"The balance between IL-1 and IL-1Ra in disease","volume":"13","author":"Arend","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"10.1016\/j.vaccine.2010.10.045_bib0010","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095","article-title":"Biologic basis for interleukin-1 in disease","volume":"87","author":"Dinarello","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2010.10.045_bib0015","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.10.045_bib0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nri2691","article-title":"The IL-1 family: regulators of immunity","volume":"10","author":"Sims","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2010.10.045_bib0025","first-page":"ii3","article-title":"The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis","volume":"42","author":"Dayer","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.vaccine.2010.10.045_bib0030","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/eji.200737989","article-title":"Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis","volume":"38","author":"Spohn","year":"2008","journal-title":"Eur J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2010.10.045_bib0035","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/labinvest.3780079","article-title":"Protective role of interleukin-1 in mycobacterial infection in IL-1 alpha\/beta double-knockout mice","volume":"80","author":"Yamada","year":"2000","journal-title":"Lab Invest"},{"issue":"2","key":"10.1016\/j.vaccine.2010.10.045_bib0040","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.4049\/jimmunol.179.2.1178","article-title":"IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection","volume":"179","author":"Fremond","year":"2007","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.10.045_bib0045","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1086\/315771","article-title":"Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis","volume":"182","author":"Juffermans","year":"2000","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2010.10.045_bib0050","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1128\/IAI.62.2.457-461.1994","article-title":"Interleukin-1 is involved in mouse resistance to Mycobacterium avium","volume":"62","author":"Denis","year":"1994","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2010.10.045_bib0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0166-2236(96)20020-7","article-title":"Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype?","volume":"19","author":"Gerlai","year":"1996","journal-title":"Trends Neurosci"},{"issue":"9","key":"10.1016\/j.vaccine.2010.10.045_bib0060","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1084\/jem.187.9.1463","article-title":"Production of mice deficient in genes for interleukin (IL)-1alpha, IL-1beta. IL-1alpha\/beta, and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion","volume":"187","author":"Horai","year":"1998","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2010.10.045_bib0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/1074-7613(95)90154-X","article-title":"Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice","volume":"3","author":"Zheng","year":"1995","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.vaccine.2010.10.045_bib0070","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.4049\/jimmunol.159.7.3364","article-title":"Phenotypic and functional characterization of mice that lack the type I receptor for IL-1","volume":"159","author":"Glaccum","year":"1997","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2010.10.045_bib0075","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.4049\/jimmunol.159.5.2452","article-title":"Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice","volume":"159","author":"Labow","year":"1997","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2010.10.045_bib0080","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1101\/gad.6.7.1190","article-title":"Gene expression during preimplantation mouse development","volume":"6","author":"Rothstein","year":"1992","journal-title":"Genes Dev"},{"issue":"5","key":"10.1016\/j.vaccine.2010.10.045_bib0085","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1084\/jem.104.5.737","article-title":"Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy","volume":"104","author":"McCune","year":"1956","journal-title":"J Exp Med"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2010.10.045_bib0090","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1016\/S0264-410X(02)00266-9","article-title":"A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses","volume":"20","author":"Jegerlehner","year":"2002","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2010.10.045_bib0095","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.4049\/jimmunol.178.11.7450","article-title":"A virus-like particle-based vaccine selectively targeting soluble TNF-alpha protects from arthritis without inducing reactivation of latent tuberculosis","volume":"178","author":"Spohn","year":"2007","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2010.10.045_bib0100","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.4049\/jimmunol.160.4.1796","article-title":"Effects of aminoguanidine on latent murine tuberculosis","volume":"160","author":"Flynn","year":"1998","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2010.10.045_bib0105","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.4049\/jimmunol.148.5.1486","article-title":"Type I IL-1 receptor blockade exacerbates murine listeriosis","volume":"148","author":"Havell","year":"1992","journal-title":"J Immunol"},{"issue":"20","key":"10.1016\/j.vaccine.2010.10.045_bib0110","doi-asserted-by":"crossref","first-page":"11008","DOI":"10.1073\/pnas.93.20.11008","article-title":"Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice","volume":"93","author":"Hirsch","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.vaccine.2010.10.045_bib0115","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1128\/IAI.67.4.1901-1909.1999","article-title":"Effects of interleukin-1 receptor antagonist overexpression on infection by Listeria monocytogenes","volume":"67","author":"Irikura","year":"1999","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2010.10.045_bib0120","first-page":"269","article-title":"Immunohistochemical demonstration of interleukin-1 receptor antagonist protein and interleukin-1 in human lymphoid tissue and granulomas","volume":"140","author":"Chensue","year":"1992","journal-title":"Am J Pathol"},{"issue":"7","key":"10.1016\/j.vaccine.2010.10.045_bib0125","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.4049\/jimmunol.0904189","article-title":"Caspase-1 independent IL-1beta production is critical for host resistance to Mycobacterium tuberculosis and does not require TLR signaling in vivo","volume":"184","author":"Mayer-Barber","year":"2010","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2010.10.045_bib0130","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/intimm\/dxn071","article-title":"Contribution of IL-1 to resistance to Streptococcus pneumoniae infection","volume":"20","author":"Kafka","year":"2008","journal-title":"Int Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2010.10.045_bib0165","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/intimm\/dxq006","article-title":"IL-1-induced inflammation promotes development of leishmaniasis in susceptible BALB\/c mice","volume":"22","author":"Voronov","year":"2010","journal-title":"Int Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2010.10.045_bib0140","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1086\/503363","article-title":"Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis","volume":"193","author":"Vonk","year":"2006","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2010.10.045_bib0145","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.4049\/jimmunol.167.12.6957","article-title":"A protective and agonistic function of IL-12p40 in mycobacterial infection","volume":"167","author":"Holscher","year":"2001","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2010.10.045_bib0150","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1365-2567.1997.00193.x","article-title":"Analysis of the local kinetics and localization of interleukin-1 alpha, tumour necrosis factor-alpha and transforming growth factor-beta, during the course of experimental pulmonary tuberculosis","volume":"90","author":"Hernandez-Pando","year":"1997","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2010.10.045_bib0155","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1465-9921-8-49","article-title":"Reduced inflammatory response in cigarette smoke exposed Mrp1\/Mdr1a\/1b deficient mice","volume":"8","author":"van der Deen","year":"2007","journal-title":"Respir Res"},{"issue":"6","key":"10.1016\/j.vaccine.2010.10.045_bib0160","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1165\/ajrcmb\/1.6.507","article-title":"Normal human alveolar macrophages have more ability than blood monocytes to produce cell-associated interleukin-1-alpha","volume":"1","author":"Sone","year":"1989","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1001529X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1001529X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T07:13:03Z","timestamp":1685862783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1001529X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0264410X1001529X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.10.045","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}